Novavax, Inc. NVAX
Regular-session close
After hours · Nov 20, 6:52 PM ET
- YTD
- +11.16%
- 1 year
- +20.10%
Held by funds
103 US ETFs and mutual funds hold NVAX · largest positions
- VTI 0.00% of fund $41.38M
- XBI 0.39% of fund $37.77M
- VB 0.02% of fund $37.21M
- NJM 0.05% of fund $36.01M
- IWM 0.04% of fund $31.78M
- VBK 0.05% of fund $20.87M
- VXF 0.02% of fund $18.88M
- FSSNX 0.04% of fund $15.63M
- IWN 0.09% of fund $11.56M
- NLO 0.07% of fund $10.41M
- PBE 2.36% of fund $10.08M
- IBB 0.09% of fund $9.77M
- VTWO 0.05% of fund $9.04M
- FSMAX 0.02% of fund $8.32M
- SCHA 0.03% of fund $6.84M
- FESM 0.10% of fund $6.44M
- VHT 0.02% of fund $4.33M
- IDNA 1.19% of fund $3.87M
- FYC 0.29% of fund $3.85M
- FSKAX 0.00% of fund $3.39M
Ownership
- Institutions 69.4%
- Insiders 5.05%
- Public and other holders 25.5%
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 9.45% | 15,594,410 | 116.49M | Sep 29, 2026 |
| Shah Capital Management | 7.38% | 12,173,481 | 90.94M | Sep 29, 2026 |
| State Street Corporation | 5.35% | 8,827,707 | 65.94M | Sep 29, 2026 |
| Vanguard Portfolio Management LLC | 4.39% | 7,249,353 | 54.15M | Sep 29, 2026 |
| Vanguard Capital Management LLC | 4.38% | 7,232,300 | 54.03M | Sep 29, 2026 |
| Sanofi | 4.17% | 6,880,481 | 51.40M | Sep 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.15% | 5,197,170 | 38.82M | Jun 29, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.79% | 4,603,628 | 34.39M | Sep 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.41% | 3,971,987 | 29.67M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.28% | 3,766,470 | 28.14M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.31% | 2,163,104 | 16.16M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.15% | 1,893,260 | 14.14M | Jun 29, 2026 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs NVAX, and what each was last paid
John Charles Jacobs, President, Chief Executive Officer & DirectorAverage age 61
| Name | Title | Pay | Age |
|---|---|---|---|
| John Charles Jacobs | President, Chief Executive Officer & Director | $1.55M | 59 |
| Mark Casey | Executive Vice President, Chief Legal Officer & Corporate Secretary | $984K | 63 |
| Elaine O'Hara | Executive Vice President & Chief Strategy Officer | $947K | 58 |
| James Patrick Kelly | Executive Vice President, Chief Financial Officer & Treasurer | $884K | 60 |
| Silvia Taylor | Executive Vice President, Chief Corporate Affairs Officer & Head of Novavax Sweden | — | — |
| Richard Crowley | Executive Vice President & Chief Operating Officer | — | 69 |
| Troy Morgan | Senior Vice President, Deputy General Counsel & Chief Compliance Officer | — | 55 |
| Erika S. Trahan | Associate Director of Investor & Public Relations | — | — |
| Naina Zaman | Director of Investor Relations | — | — |
| Ian J. Watkins | Executive Vice President & Chief Human Resources Officer | — | 63 |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ALTON GREGG H | Director | Conversion of Exercise of derivative security | Jun 17, 2026 | 47,685 |
| CASEY MARK J | Officer | Conversion of Exercise of derivative security | Mar 2, 2026 | 90,067 |
| DOUGLAS RICHARD H | Director | Conversion of Exercise of derivative security | Jun 17, 2026 | 73,220 |
| JACOBS JOHN C | Chief Executive Officer | Conversion of Exercise of derivative security | Mar 2, 2026 | 225,680 |
| KELLY JAMES PATRICK | Chief Financial Officer | Conversion of Exercise of derivative security | Mar 5, 2026 | 130,599 |
| MOTT DAVID M | Director | Conversion of Exercise of derivative security | Jun 17, 2026 | 79,770 |
